Literature DB >> 4744920

Induction of skin resistance to vaccinia virus in rabbits by vaccinia-soluble early antigens.

Y Ueda, I Tagaya.   

Abstract

The immunological role of vaccinia-soluble early antigen was examined in rabbits. The antigens were prepared from HeLa cells infected with a conditional lethal mutant of vaccinia virus, which induces in these cells early antigens including those responsible for surface immunofluorescence of infected cells, but not viral DNA and late protein syntheses. Immunization of rabbits with the antigens in Freund's complete adjuvant induced complement-fixing antibody but neither detectable circulating neutralizing antibody nor any detectable level of inhibitory substance or interferon in the skin of the animals. When immunized animals were inoculated intradermally with vaccinia virus, multiplication of virus in the skin was greatly inhibited, being accompanied by an earlier appearance as well as an accelerated wane of the local reactions. The resistance could not be transferred passively by the serum of immunized animals to normal rabbits. Immunization of rabbits with the antigens without the adjuvant not only failed to inhibit but, contrariwise, enhanced the multiplication of intradermally inoculated vaccinia virus, inducing heavy skin lesions and exalted virus multiplication.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4744920      PMCID: PMC2139429          DOI: 10.1084/jem.138.5.1033

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  20 in total

1.  Vaccinia Gangrenosa with normal humoral antibodies. A case possibly due to deficient cellular immunity treated with N-methylisatin beta-thiosemicarbazone (Compound 33T57, Marboran).

Authors:  O Hansson; S G Johansson; B Vahlquist
Journal:  Acta Paediatr Scand       Date:  1966-05

2.  Immune hemadsorption by cells infected with poxviruses.

Authors:  H Miyamoto; S Kato
Journal:  Biken J       Date:  1968-12

3.  Immunological relationship between herpes simplex virus and B virus.

Authors:  Y Ueda; I Tgaya; K Shiroki
Journal:  Arch Gesamte Virusforsch       Date:  1968

4.  A specific surface antigen induced by poxvirus.

Authors:  Y Ueda; M Ito; I Tagaya
Journal:  Virology       Date:  1969-05       Impact factor: 3.616

Review 5.  Cell-mediated immune responses to virus infections and virus-induced tumours.

Authors:  A C Allison
Journal:  Br Med Bull       Date:  1967-01       Impact factor: 4.291

6.  An in vitro assay for cellular hypersensitivity in man.

Authors:  R E Rocklin; O L Meyers; J R David
Journal:  J Immunol       Date:  1970-01       Impact factor: 5.422

7.  The development of skin resistance and hypersensitivity following inactivated vaccinia virus vaccines in rabbits.

Authors:  T A McNeill
Journal:  J Hyg (Lond)       Date:  1966-03

8.  Delayed hypersensitivity in vaccinia-infected mice. I. Antigen(s) responsible for developing delayed hypersensitivity.

Authors:  S Ueda; T Nozima
Journal:  Acta Virol       Date:  1969-11       Impact factor: 1.162

9.  Cellular immunity in vaccinia infection of mice. Anti-thymocyte serum effects on primary and secondary responsiveness.

Authors:  M S Hirsch; A J Nahmias; F A Murphy; J H Kramer
Journal:  J Exp Med       Date:  1968-07-01       Impact factor: 14.307

10.  Mechanisms of recovery from a generalized viral infection: mousepox. I. The effects of anti-thymocyte serum.

Authors:  R V Blanden
Journal:  J Exp Med       Date:  1970-11       Impact factor: 14.307

View more
  6 in total

1.  Induction and in Vitro demonstration of cellular immunity to DNA and RNA viruses in guinea-pigs.

Authors:  U Koszinowski; G Bandlow
Journal:  Clin Exp Immunol       Date:  1975-04       Impact factor: 4.330

2.  Polypeptide analysis with monoclonal antibodies of A type inclusion bodies induced by cowpox virus.

Authors:  N Kitamoto; S Tanimoto; K Hiroi; T Tanaka; H Miyamoto; N Wakamiya; K Ikuta; S Ueda; S Kato
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

3.  Feasibility of UV-inactivated vaccinia virus in the modification of tumor cells for augmentation of their immunogenicity.

Authors:  N Wakamiya; Y L Wang; H Imai; H X Gu; S Ueda; S Kato
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

4.  Cross-reactivity between cowpox and vaccinia viruses with monoclonal antibodies. Brief report.

Authors:  N Kitamoto; E Goto; S Tanimoto; T Tanaka; H Miyamoto; N Wakamiya; K Ikuta; S Ueda; S Kato
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

5.  A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types.

Authors:  C J McMahan; J L Slack; B Mosley; D Cosman; S D Lupton; L L Brunton; C E Grubin; J M Wignall; N A Jenkins; C I Brannan
Journal:  EMBO J       Date:  1991-10       Impact factor: 11.598

6.  The orthopoxvirus type I IFN binding protein is essential for virulence and an effective target for vaccination.

Authors:  Ren-Huan Xu; Matthew Cohen; Yong Tang; Eric Lazear; J Charles Whitbeck; Roselyn J Eisenberg; Gary H Cohen; Luis J Sigal
Journal:  J Exp Med       Date:  2008-04-07       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.